229 related articles for article (PubMed ID: 26743380)
41. Frequency of breast cancer subtypes among African American women in the AMBER consortium.
Allott EH; Geradts J; Cohen SM; Khoury T; Zirpoli GR; Bshara W; Davis W; Omilian A; Nair P; Ondracek RP; Cheng TD; Miller CR; Hwang H; Thorne LB; O'Connor S; Bethea TN; Bell ME; Hu Z; Li Y; Kirk EL; Sun X; Ruiz-Narvaez EA; Perou CM; Palmer JR; Olshan AF; Ambrosone CB; Troester MA
Breast Cancer Res; 2018 Feb; 20(1):12. PubMed ID: 29409530
[TBL] [Abstract][Full Text] [Related]
42. Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative.
Kaklamani VG; Hoffmann TJ; Thornton TA; Hayes G; Chlebowski R; Van Horn L; Mantzoros C
Breast Cancer Res Treat; 2013 Jun; 139(2):461-8. PubMed ID: 23624817
[TBL] [Abstract][Full Text] [Related]
43. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
Haiman CA; Chen GK; Vachon CM; Canzian F; Dunning A; Millikan RC; Wang X; Ademuyiwa F; Ahmed S; Ambrosone CB; Baglietto L; Balleine R; Bandera EV; Beckmann MW; Berg CD; Bernstein L; Blomqvist C; Blot WJ; Brauch H; Buring JE; Carey LA; Carpenter JE; Chang-Claude J; Chanock SJ; Chasman DI; Clarke CL; Cox A; Cross SS; Deming SL; Diasio RB; Dimopoulos AM; Driver WR; Dünnebier T; Durcan L; Eccles D; Edlund CK; Ekici AB; Fasching PA; Feigelson HS; Flesch-Janys D; Fostira F; Försti A; Fountzilas G; Gerty SM; ; Giles GG; Godwin AK; Goodfellow P; Graham N; Greco D; Hamann U; Hankinson SE; Hartmann A; Hein R; Heinz J; Holbrook A; Hoover RN; Hu JJ; Hunter DJ; Ingles SA; Irwanto A; Ivanovich J; John EM; Johnson N; Jukkola-Vuorinen A; Kaaks R; Ko YD; Kolonel LN; Konstantopoulou I; Kosma VM; Kulkarni S; Lambrechts D; Lee AM; Marchand LL; Lesnick T; Liu J; Lindstrom S; Mannermaa A; Margolin S; Martin NG; Miron P; Montgomery GW; Nevanlinna H; Nickels S; Nyante S; Olswold C; Palmer J; Pathak H; Pectasides D; Perou CM; Peto J; Pharoah PD; Pooler LC; Press MF; Pylkäs K; Rebbeck TR; Rodriguez-Gil JL; Rosenberg L; Ross E; Rüdiger T; Silva Idos S; Sawyer E; Schmidt MK; Schulz-Wendtland R; Schumacher F; Severi G; Sheng X; Signorello LB; Sinn HP; Stevens KN; Southey MC; Tapper WJ; Tomlinson I; Hogervorst FB; Wauters E; Weaver J; Wildiers H; Winqvist R; Van Den Berg D; Wan P; Xia LY; Yannoukakos D; Zheng W; Ziegler RG; Siddiq A; Slager SL; Stram DO; Easton D; Kraft P; Henderson BE; Couch FJ
Nat Genet; 2011 Oct; 43(12):1210-4. PubMed ID: 22037553
[TBL] [Abstract][Full Text] [Related]
44. Genetic variants in microRNAs and breast cancer risk in African American and European American women.
Yao S; Graham K; Shen J; Campbell LE; Singh P; Zirpoli G; Roberts M; Ciupak G; Davis W; Hwang H; Khoury T; Bovbjerg DH; Jandorf L; Pawlish KS; Bandera EV; Liu S; Ambrosone CB; Zhao H
Breast Cancer Res Treat; 2013 Oct; 141(3):447-59. PubMed ID: 24062209
[TBL] [Abstract][Full Text] [Related]
45. [Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR].
Ren L; Zhang B; Cao XC; Chen Y; Ge J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):445-8. PubMed ID: 20677155
[TBL] [Abstract][Full Text] [Related]
46. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
47. Breast cancer subtypes and previously established genetic risk factors: a bayesian approach.
O'Brien KM; Cole SR; Engel LS; Bensen JT; Poole C; Herring AH; Millikan RC
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):84-97. PubMed ID: 24177593
[TBL] [Abstract][Full Text] [Related]
48. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
Fu F; Wang C; Huang M; Song C; Lin S; Huang H
Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
[TBL] [Abstract][Full Text] [Related]
49. An admixture scan in 1,484 African American women with breast cancer.
Fejerman L; Haiman CA; Reich D; Tandon A; Deo RC; John EM; Ingles SA; Ambrosone CB; Bovbjerg DH; Jandorf LH; Davis W; Ciupak G; Whittemore AS; Press MF; Ursin G; Bernstein L; Huntsman S; Henderson BE; Ziv E; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3110-7. PubMed ID: 19843668
[TBL] [Abstract][Full Text] [Related]
50. Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.
Zhang J; Yao S; Hu Q; Zhu Q; Liu S; Lunetta KL; Haddad SA; Yang N; Shen H; Hong CC; Sucheston-Campbell L; Ruiz-Narvaez EA; Bensen JT; Troester MA; Bandera EV; Rosenberg L; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
Carcinogenesis; 2016 Oct; 37(10):951-956. PubMed ID: 27485598
[TBL] [Abstract][Full Text] [Related]
51. Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study.
Hutter CM; Young AM; Ochs-Balcom HM; Carty CL; Wang T; Chen CT; Rohan TE; Kooperberg C; Peters U
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1950-9. PubMed ID: 21795501
[TBL] [Abstract][Full Text] [Related]
52. Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes.
Zhu K; Davidson NE; Hunter S; Yang X; Payne-Wilks K; Roland CL; Phillips D; Bentley C; Dai M; Williams SM
Cancer Causes Control; 2003 Nov; 14(9):827-36. PubMed ID: 14682440
[TBL] [Abstract][Full Text] [Related]
53. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.
Prentice RL; Huang Y; Hinds DA; Peters U; Pettinger M; Cox DR; Beilharz E; Chlebowski RT; Rossouw JE; Caan B; Ballinger DG
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3079-85. PubMed ID: 19861516
[TBL] [Abstract][Full Text] [Related]
54. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
Garcia-Closas M; Couch FJ; Lindstrom S; Michailidou K; Schmidt MK; Brook MN; Orr N; Rhie SK; Riboli E; Feigelson HS; Le Marchand L; Buring JE; Eccles D; Miron P; Fasching PA; Brauch H; Chang-Claude J; Carpenter J; Godwin AK; Nevanlinna H; Giles GG; Cox A; Hopper JL; Bolla MK; Wang Q; Dennis J; Dicks E; Howat WJ; Schoof N; Bojesen SE; Lambrechts D; Broeks A; Andrulis IL; Guénel P; Burwinkel B; Sawyer EJ; Hollestelle A; Fletcher O; Winqvist R; Brenner H; Mannermaa A; Hamann U; Meindl A; Lindblom A; Zheng W; Devillee P; Goldberg MS; Lubinski J; Kristensen V; Swerdlow A; Anton-Culver H; Dörk T; Muir K; Matsuo K; Wu AH; Radice P; Teo SH; Shu XO; Blot W; Kang D; Hartman M; Sangrajrang S; Shen CY; Southey MC; Park DJ; Hammet F; Stone J; Veer LJ; Rutgers EJ; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Peto J; Schrauder MG; Ekici AB; Beckmann MW; Dos Santos Silva I; Johnson N; Warren H; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Truong T; Laurent-Puig P; Kerbrat P; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Perez JI; Menéndez P; Müller H; Arndt V; Stegmaier C; Lichtner P; Lochmann M; Justenhoven C; Ko YD; ; Muranen TA; Aittomäki K; Blomqvist C; Greco D; Heikkinen T; Ito H; Iwata H; Yatabe Y; Antonenkova NN; Margolin S; Kataja V; Kosma VM; Hartikainen JM; Balleine R; ; Tseng CC; Berg DV; Stram DO; Neven P; Dieudonné AS; Leunen K; Rudolph A; Nickels S; Flesch-Janys D; Peterlongo P; Peissel B; Bernard L; Olson JE; Wang X; Stevens K; Severi G; Baglietto L; McLean C; Coetzee GA; Feng Y; Henderson BE; Schumacher F; Bogdanova NV; Labrèche F; Dumont M; Yip CH; Taib NA; Cheng CY; Shrubsole M; Long J; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Knight JA; Glendon G; Mulligan AM; Tollenaar RA; Seynaeve CM; Kriege M; Hooning MJ; van den Ouweland AM; van Deurzen CH; Lu W; Gao YT; Cai H; Balasubramanian SP; Cross SS; Reed MW; Signorello L; Cai Q; Shah M; Miao H; Chan CW; Chia KS; Jakubowska A; Jaworska K; Durda K; Hsiung CN; Wu PE; Yu JC; Ashworth A; Jones M; Tessier DC; González-Neira A; Pita G; Alonso MR; Vincent D; Bacot F; Ambrosone CB; Bandera EV; John EM; Chen GK; Hu JJ; Rodriguez-Gil JL; Bernstein L; Press MF; Ziegler RG; Millikan RM; Deming-Halverson SL; Nyante S; Ingles SA; Waisfisz Q; Tsimiklis H; Makalic E; Schmidt D; Bui M; Gibson L; Müller-Myhsok B; Schmutzler RK; Hein R; Dahmen N; Beckmann L; Aaltonen K; Czene K; Irwanto A; Liu J; Turnbull C; ; Rahman N; Meijers-Heijboer H; Uitterlinden AG; Rivadeneira F; ; Olswold C; Slager S; Pilarski R; Ademuyiwa F; Konstantopoulou I; Martin NG; Montgomery GW; Slamon DJ; Rauh C; Lux MP; Jud SM; Bruning T; Weaver J; Sharma P; Pathak H; Tapper W; Gerty S; Durcan L; Trichopoulos D; Tumino R; Peeters PH; Kaaks R; Campa D; Canzian F; Weiderpass E; Johansson M; Khaw KT; Travis R; Clavel-Chapelon F; Kolonel LN; Chen C; Beck A; Hankinson SE; Berg CD; Hoover RN; Lissowska J; Figueroa JD; Chasman DI; Gaudet MM; Diver WR; Willett WC; Hunter DJ; Simard J; Benitez J; Dunning AM; Sherman ME; Chenevix-Trench G; Chanock SJ; Hall P; Pharoah PD; Vachon C; Easton DF; Haiman CA; Kraft P
Nat Genet; 2013 Apr; 45(4):392-8, 398e1-2. PubMed ID: 23535733
[TBL] [Abstract][Full Text] [Related]
56. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
57. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of FGFR2 gene polymorphism in women with breast cancer.
Salehi Z; Afzali S; Shabanipour S; Rahimi A
Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):94-7. PubMed ID: 26025410
[TBL] [Abstract][Full Text] [Related]
59. A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.
Bethea TN; Rosenberg L; Hong CC; Troester MA; Lunetta KL; Bandera EV; Schedin P; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res; 2015 Feb; 17(1):22. PubMed ID: 25849024
[TBL] [Abstract][Full Text] [Related]
60. Evaluating genome-wide association study-identified breast cancer risk variants in African-American women.
Long J; Zhang B; Signorello LB; Cai Q; Deming-Halverson S; Shrubsole MJ; Sanderson M; Dennis J; Michailidou K; Easton DF; Shu XO; Blot WJ; Zheng W
PLoS One; 2013; 8(4):e58350. PubMed ID: 23593120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
